FOXA1 functions as a pioneer factor for ER, promoting luminal-lineage proliferation [12, 13], whereas GRHL2 is known to be involved in reprogramming ER signaling in breast cancer development [14]. The gene discussed is GRHL2; the disease is breast cancer.